Bone Biologics

Bone Biologics Gross Margin

Gross Margin of Bone Biologics (BBLG) as of Nov 19, 2026.

Gross Margin

-

Last updated:

Gross Margin of Bone Biologics is 2026 - . Gross Margin of Bone Biologics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bone Biologics Stock analysis

What does Bone Biologics do? Bone Biologics Corp. generates revenue through the development and sale of its NELL-1/DBM Fusion Device, a bone regeneration product for spinal fusion procedures. The device combines NELL-1, a recombinant human protein, with demineralized bone matrix (DBM) to provide targeted bone regeneration control. Medical professionals use the product for spine implants, non-union trauma cases, and osteoporosis treatments. The company's platform technology, centered on NELL-1, is developed through laboratory and animal research to support applications in bone void filling and skeletal regeneration. The firm focuses on osteopromotive applications using NELL-1, a skeletal-specific growth factor proven in laboratory models to replicate human growth and development. NELL-1 is marketed as a bone void filler and is integrated into spinal fusion devices. The company's revenue streams derive from the commercialization of NELL-1-based products targeting orthopedic and spinal surgery markets. Medical device companies and healthcare providers purchase the NELL-1/DBM Fusion Device for clinical use in bone regeneration procedures. Bone Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bone Biologics stock

On Eulerpool you can find the complete historical development of Gross Margin Bone Biologics since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Bone Biologics with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bone Biologics

All Key Metrics — Bone Biologics